Search
for
Sort by
Research 91–120 of 1000+
- Ottawa, Ontario, Canada, February 13–16, 2013
- High Real-World Medication Adherence and Durable Clinical Benefit in Medicare Patients Treated with 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- Peripheral Neuroprotective and Immunomodulatory Effects of 5α-Reductase Inhibitors in Parkinson’s Disease Models
- Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies
- Effects of Solvent System and Storage Condition on Chemical Stability of 5(alpha)-Reductase Inhibitor Compounds in Tectona grandis L.f. Leaf Extracts
- Hormone Blocking Anticancer Drugs
- Association of 5α-Reductase Inhibitors With Dementia, Depression, and Suicide
- Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients
- Physiology and Medical Treatments for Alopecia
- Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors
- Optimal Management of Frontal Fibrosing Alopecia: A Practical Guide
- 5‐α reductase inhibitors and the risk of anaemia among men with benign prostatic hyperplasia: A population‐based cohort study
- Benign Prostatic Hyperplasia Pharmacotherapy and Incident Ocular Surface Disease: Comparative Risk of Alpha-Blockers vs 5-Alpha Reductase Inhibitors
- Hutchinson-Gilford syndrome: History, causes, phenotype and research advances
- Dual blockage of P-cadherin and c-Met synergistically inhibits the growth of head and neck cancer
- Aberrant Activation of the Hedgehog Pathway in Cutaneous Melanoma: Therapeutic Potential of Pharmacological Inhibitors
- Prostaglandins and Skin Cancer: An Old Pathway With New Insights in Cutaneous Oncology
- Inhibiting Janus kinases to treat alopecia areata
- Premature aging syndromes: From patients to mechanism
- Alopecia Areata
- Treatment of Lichen Planopilaris and Frontal Fibrosing Alopecia: A Retrospective, Real-Life Analysis in a Tertiary Center in Germany
- Diphlorethohydroxycarmalol, Isolated from Ishige okamurae, Increases Prostaglandin E<sub>2</sub>through the Expression of Cyclooxygenase-1 and -2 in HaCaT Human Keratinocytes
- Diseases of the Canine Prostate Gland
- Skin Pigmentation Types, Causes and Treatment—A Review
- Protein Kinase C δ Overexpressing Transgenic Mice Are Resistant to Chemically but not to UV Radiation–Induced Development of Squamous Cell Carcinomas: A Possible Link to Specific Cytokines and Cyclooxygenase-2
- A Comprehensive Review on Skin Pigmentation-Types, Causes, and Treatment
- Investigation of In Vitro and In Silico Anti-Inflammatory Potential of Carthamus caeruleus L. Root Juice
- Montagna Symposium 2013—Light and Skin: How Light Sustains, Damages, Treats, Images and Modifies Skin Biology
- Chemical Constituents from Osmanthus fragrans var. aurantiacus Makino with Their In Vitro and In Silico Studies Target Anti-Inflammation by Suppressing ERK 1/2 MAPK Signaling
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management